{
    "Pipeline Outcome": "Sufficient reads mapped to M. tuberculosis (H37Rv v3) for genome assembly, resistance prediction and relatedness assessment.",
    "Organism Identification": {
        "Human Reads": null,
        "Unclassified Reads": 112,
        "Non-Mycobacterium Bacteria Reads": 1076,
        "Mycobacterium Reads": 1396026
    },
    "Mycobacterium Results": {
        "Summary": [
            {
                "Name": "M. tuberculosis (lineage 4.3.3)",
                "Num Reads": 1371570,
                "Coverage": 98.9753,
                "Depth": 42.5051
            }
        ],
        "Species": [
            {
                "Name": "M.tuberculosis",
                "Num Reads": 1371570,
                "Coverage": 98.9753,
                "Mean Depth": 42.5051,
                "Length": 4411532
            }
        ],
        "Phylogenic Group": [
            {
                "Name": "Mycobacterium_tuberculosis_complex",
                "Coverage": 99.814,
                "Median Depth": 38
            }
        ],
        "Subspecies": [
            {
                "Name": "Mycobacterium_tuberculosis",
                "Coverage": 99.204,
                "Median Depth": 36
            }
        ],
        "Lineage": [
            {
                "Name": "lineage4.3.3",
                "Coverage": 100,
                "Median Depth": 24
            }
        ]
    },
    "Genomes": [
        {
            "Name": "M. tuberculosis",
            "Sequencing Quality": {
                "Mapped To": "M. tuberculosis (H37Rv v3) NC_000962.3",
                "Num Reads": 1371570,
                "Coverage": 98.1706,
                "Mean Depth": 42.5051,
                "Mixed calls": 60,
                "Null calls": 80706,
                "Reference genome length": 4411532
            },
            "Resistance Prediction": {
                "Resistance Prediction Summary": {
                    "First-line treatment": {
                        "Isoniazid (INH)": "U",
                        "Rifampicin (RIF)": "S",
                        "Pyrazinamide (PZA)": "S",
                        "Ethambutol (EMB)": "S"
                    },
                    "Second-line treatment": {
                        "Moxifloxacin (MXF)": "S",
                        "Levofloxacin (LEV)": "S",
                        "Linezolid (LZD)": "S",
                        "Bedaquiline (BDQ)": "S"
                    },
                    "Reserve treatment": {
                        "Amikacin (AMI)": "S",
                        "Kanamycin (KAN)": "S",
                        "Streptomycin (STM)": "S",
                        "Capreomycin (CAP)": "S",
                        "Ethionamide (ETH)": "U",
                        "Delamanid (DLM)": "S",
                        "Clofazimine (CFZ)": "S"
                    }
                },
                "Resistance Prediction Detail": [
                    {
                        "Drug Name": "ETH",
                        "Mutations": [
                            {
                                "Gene": "fabG1",
                                "Mutation": "T4I",
                                "Position": 4,
                                "Ref": "aca",
                                "Alt": "ata",
                                "Coverage": [
                                    0,
                                    54
                                ],
                                "Prediction": "U",
                                "Evidence": {
                                    "Observed_samples": {
                                        "Present_SOLO_SR": 5,
                                        "Present_SOLO_R": 1,
                                        "Present_SOLO_S": 4
                                    },
                                    "Additional grading criteria applied": null,
                                    "FINAL CONFIDENCE GRADING": "3) Uncertain significance",
                                    "INITIAL CONFIDENCE GRADING": "3) Uncertain significance",
                                    "WHO HGVS": "inhA_c.-752C>T"
                                }
                            }
                        ]
                    },
                    {
                        "Drug Name": "INH",
                        "Mutations": [
                            {
                                "Gene": "fabG1",
                                "Mutation": "T4I",
                                "Position": 4,
                                "Ref": "aca",
                                "Alt": "ata",
                                "Coverage": [
                                    0,
                                    54
                                ],
                                "Prediction": "U",
                                "Evidence": {
                                    "reporting_rule": "True"
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "Metadata": {
        "Pipeline build": "97c97e3",
        "Reference Data Files": {
            "manifest": "manifest_20231001",
            "species_list": "species_list_manifest_20250324.csv",
            "name_mapping": "competitive_mapping_mykrobe_names_20241105.csv",
            "ref_files": "Ref_prepare",
            "tb_ref_genome": "NC_000962.3.gbk",
            "tb_amr_cat": "NC_000962.3_WHO-UCN-TB-2023.5_v2.1_GARC1_RFUS.csv",
            "sundial_ref": "h37rv_20231215.fa.gz"
        }
    }
}